Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 10.68 USD 2.99% Market Closed
Market Cap: 65.7m USD

Wall Street
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

There are no price targets for ALGS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aligos Therapeutics Inc Competitors:
Price Targets
TVTX
Travere Therapeutics Inc
23% Upside
CRNX
Crinetics Pharmaceuticals Inc
70% Upside
EXEL
Exelixis Inc
4% Upside
ASMB
Assembly Biosciences Inc
11% Upside
ADMA
ADMA Biologics Inc
42% Upside
005690
Pharmicell Co Ltd
12% Upside
MSB
Mesoblast Ltd
22% Upside
CRSP
CRISPR Therapeutics AG
43% Upside

Revenue
Forecast

Revenue Estimate
Aligos Therapeutics Inc

The compound annual growth rate of Aligos Therapeutics Inc's revenue for the next 4 years is 121%.

N/A
Past Growth
121%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGS's stock price target?
Not Available

ALGS doesn't have any price targets made by Wall Street professionals.

What is Aligos Therapeutics Inc's Revenue forecast?
Projected CAGR
121%

The compound annual growth rate of Aligos Therapeutics Inc's revenue for the next 4 years is 121%.

Back to Top